MSA News

Mesa Science Associates and Bryn Pharma Announce Initial Study of a New Approach to Treating Anaphylaxis

Posted on:

On November 10, 2019, Mr. Michael Mesa, President and CEO of Mesa Science Associates (MSA), announced the presentation of a non-clinical study regarding Nasal Administration of Epinephrine. The results were presented by Kenneth Dretchen Ph.D., CSO and Principle Investigator at MSA. The study was presented in a poster at the American College of Allergy, Asthma, and Immunology (ACAAI) annual conference in Houston, Texas on November 10, 2019.  The poster entitled,  “Intranasal Effects on Pharmacokinetics and Heart Rate in a Nasal Congestion Canine Model”  is the first in a series of publications to be presented by MSA that detail the results…

Read More »

Bryn Pharma Research on Epinephrine Nasal Spray Presented at The American College of Allergy, Asthma and Immunology Annual Meeting

Posted on:

– Preclinical Study of Intranasal Epinephrine Administration in Nasal Congestion Model Demonstrated Faster Absorption of Epinephrine in Canines – Multicenter Study Showed Healthcare Professional Preference for Bi-dose Epinephrine Nasal Spray Over EpiPen® Auto-Injector HOUSTON, Nov. 10, 2019 /PRNewswire/ — Bryn Pharma, LLC (“Bryn” or the “Company”), a privately held pharmaceutical company dedicated to finding a better way for patients and caregivers to treat anaphylaxis, announced that the results of two studies supporting the potential benefits of its BRYN-NDS1C product candidate, Bi-dose Epinephrine Nasal Spray, were presented today at the Annual Scientific Meeting of the American College of Asthma, Allergy and Immunology (ACAAI) in Houston, TX….

Read More »

Dr. Ken Dretchen Appointed to PhRMA Review Committee

Posted on:

Dr. Ken Dretchen, Chief Scientific Officer served as a member of the Basic Pharmacology Advisory Committee for the Pharmaceutical Research and Manufacturers of America Foundation (PhRMA) in Washington, D.C. on November 2nd and 3rd, 2017.  This Committee reviewed Grant Applications in the following categories: Pre-Doctoral awards, Post-Doctoral awards, Research Starter grants, and Sabbatical Leaves. The Advisory Committee consisted of academic and industry leaders throughout the country.

MSA at NIH’s Countermeasures Against Chemical Threats (CounterACT) Symposium

Posted on:

During the week beginning Sunday 6/11/17 Michael Mesa , President of Mesa Science Associates , will represent the company at the 11th Annual NIH CounterAct Research Symposium. This year’s event will be held in Boston Mass.  and will be hosted by Brigham and Women’s Hospital and The Harvard Medical School Center for CounterAct Excellence. For the 6th year Mr. Mesa will join clients and colleagues from around the world for this important medical/pharmaceutical  conference. This years’ event includes a special treat which is  a dinner at John F. Kennedy Presidential Library and Museum.

Mesa Science Associates to join CounterACT Researchers in Boston

Posted on:

Mesa Science Associates (MSA) announced today, April 12, 2017  plans to join Counter Act researchers and scientists at the 11th Annual NIH CounterACT Network Research Symposium. The Symposium will be held from  Monday, June 12 through Wednesday, June 14, 2017 at the Revere Hotel in Boston Mass. The company will be represented by MSA President, Mr. Michael Mesa. This will be Mr. Mesa’s 8th year at this unique conference and his 6th year representing MSA. He will join  colleagues and customers from around the country at this important scientific conference. MSA provides technical support to certain CounterACT researchers who are developing drugs and treatments aimed at…

Read More »

Mesa Science at the National Museum for Health and Medicine

Posted on:

Recently, Michael Mesa, MSA President and CEO, was invited by Dr. Adrianne Noe , the curator of the National Museum for Health and Medicine (NMHM) to join her and her staff for a private guided tour of the museum. The trip was arranged following a request from Dr. Noe and Mr. Chan from the pentagon for a briefing on the history of the development of automatic syringes for the self-administration of drugs and antidotes by individual soldiers in the field. Following a telephonic briefing on this subject, Dr. Noe graciously extended an invitation to Mr. Mesa for an escorted tour of the Museum   The NMHM was…

Read More »

Dr. Ken Dretchen Appointed to PhRMA Review Committee

Posted on:

Dr. Ken Dretchen, Chief Scientific Officer served as a member of the Basic Pharmacology Advisory Committee for the Pharmaceutical Research and Manufacturers of America Foundation (PhRMA) in Washington, D.C. on November 2nd and 3rd, 2016.  This Committee reviewed Grant Applications in the following categories: Pre-Doctoral awards, Post-Doctoral awards, Research Starter grants, and Sabbatical Leaves. The Advisory Committee consisted of academic and industry leaders throughout the country.

Mesa Science Associates, Inc. Receives 2016 Best of Frederick Award

Posted on:

Press Release FOR IMMEDIATE RELEASE Mesa Science Associates, Inc. Receives 2016 Best of Frederick Award Frederick Award Program Honors the Achievement FREDERICK August 25, 2016 –Mesa Science Associates, Inc. has been selected for the 2016 Best of Frederick Award in the Scientific Research & Development Services category by the Frederick Award Program. Each year, the Frederick Award Program identifies companies that we believe have achieved exceptional marketing success in their local community and business category. These are local companies that enhance the positive image of small business through service to their customers and our community. These exceptional companies help make…

Read More »

A Thank You To The MSA Team

Posted on:

Last fall, I started as an intern for the pharmaceutical development consulting firm Mesa Science Associates (MSA) with little to no experience in the pharmaceutical industry, but quickly gained a strong working knowledge of the field. Lo and behold Sir Isaac Newton’s famous quote, “If I have seen further than others, it is by standing upon the shoulders of giants” defined my experience at MSA. Before I knew it, my internship turned into a full-time position and I was getting my hands in projects that I wouldn’t ever have dreamed to have a part in. I want to thank the…

Read More »

Chief Science Officer of MSA Elected to The Science Advisory Board

Posted on:

The Science Advisory Board invites Dr. Ken Dretchen to join a global community of scientific professionals to collaborate on shaping the future of science and technology. Established in 1997, The Science Advisory Board is an international community of science and medical experts. Members advise and consult major life science companies and earn honoraria for their feedback. Only professionals working in a scientific field are permitted to join. The Science Advisory Board’s clients include industry leaders such as GE Healthcare, Roche, Merck, Thermofisher, Illumina, etc.